4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-16-106217
Options or other derivatives
- Vice President & Secretary acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SEGALL JUDITH · Vice President & Secretary
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-01-20 | Grant or award : show line 1 in the form Option to Purchase Common Shares | +25,000 | $2.50 | 2026-01-19 | 25,000 | 25,000 | D |
Loading xslF345X03/doc4.xml…